Why the study?
There is a strong association between inflammation and atrial fibrillation, but the relationship between hs-CRP as an inflammatory marker and thromboembolism risk in non-valvular AF patients needed assessment.
Does elevated hs-CRP predict the presence of thromboembolic markers on TEE in patients with non-valvular atrial fibrillation?
Observational (n=100)
Does elevated hs-CRP predict the presence of thromboembolic markers on TEE in patients with non-valvular atrial fibrillation?
Answers are grounded in this paper and cite their sources.
Elevated hs-CRP levels (≥4.5 mg/dl) are strongly associated with the presence of echocardiographic thromboembolic markers in patients with non-valvular atrial fibrillation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
A 2017 study conducted an observational in non valvular atrial fibrillation (n=100). High-sensitivity C-reactive protein (hs-CRP) ≥4.5 mg/dl vs. hs-CRP <4.5 mg/dl was evaluated on LAA thrombus (p=< 0.001).
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: